These include elevated levels of cathepsin D and IL-18, which are associated with reduced risk of herpes zoster, as well as increased risk of postherpetic neuralgia with elevated levels of Ficolin-3 and IL-2 receptor α. Here, CTSD is linked to postherpetic neuralgia.